, FSD Pharma Inc (NASDAQ:HUGE)’s traded shares were 19.29 million, with the beta value of the company hitting 0.59. The 52-week high for the HUGE share is $1.68, that puts it down -888.24 from that peak though still a striking 5.88% gain since the share price plummeted to a 52-week low of $0.16. The company’s market capitalization is $7.04M, and the average trade volume was 511.16K shares over the past three months.
FSD Pharma Inc (NASDAQ:HUGE) trade information
FSD Pharma Inc (HUGE) registered a 2.35% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.35% in intraday trading to $0.17, hitting a weekly high. The stock’s 5-day price performance is 1.75%, and it has moved by -45.11% in 30 days. Based on these gigs, the overall price performance for the year is -85.32%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
FSD Pharma Inc (HUGE) estimates and forecasts
Statistics show that FSD Pharma Inc has outperformed its competitors in share price, compared to the industry in which it operates. FSD Pharma Inc (HUGE) shares have gone down -80.93% during the last six months, with a year-to-date growth rate more than the industry average at 52.17% against 13.40.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 710k as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 710k by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 31.10%. While earnings are projected to return 52.17% in 2024.
HUGE Dividends
FSD Pharma Inc is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
